Would be juicy, if plays out, u should try :)Strong buy analyst recommendations on this stock: avg price target - 12
Also daily oversold, and now painting possible cup and handle formation
−2.09USD
−102.701MUSD
2.073MUSD
21.331M
About Omega Therapeutics, Inc.
Sector
Industry
CEO
Mahesh Karande
Website
Headquarters
Cambridge
Employees (FY)
117
Founded
2016
ISIN
US68217N1054
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
